CN Patent

CN106456787B — Pan-raf激酶抑制剂的医药调配物、其制备方法以及使用方法

Assigned to Dow Treatment 1 · Expires 2020-12-18 · 5y expired

What this patent protects

本发明涉及一种用于治疗癌症的包含化合物1或其医药学上可接受的盐的医药组合物以及其制备方法。本发明还涉及根据间歇给药方案向患者投与所述医药组合物。

USPTO Abstract

本发明涉及一种用于治疗癌症的包含化合物1或其医药学上可接受的盐的医药组合物以及其制备方法。本发明还涉及根据间歇给药方案向患者投与所述医药组合物。

Drugs covered by this patent

Patent Metadata

Patent number
CN106456787B
Jurisdiction
CN
Classification
—
Expires
2020-12-18
Drug substance claim
No
Drug product claim
No
Assignee
Dow Treatment 1
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.